9-Jun-2026
Globe Newswire (Tue, 9-Jun 1:47 PM ET)
Did Five Below, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Fri, 5-Jun 3:29 PM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Fri, 5-Jun 12:51 PM ET)
PRNewswire (Thu, 4-Jun 10:00 AM ET)
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm
Business Wire (Tue, 2-Jun 4:25 PM ET)
Doximity to Present at the William Blair 46th Annual Growth Stock Conference
Business Wire (Thu, 21-May 4:01 PM ET)
Doximity’s AI Partnership with Aledade Signals Push Into Value-Based Care
Market Chameleon (Thu, 14-May 5:53 AM ET)
Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings
Business Wire (Wed, 13-May 4:02 PM ET)
Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results
Business Wire (Wed, 13-May 4:01 PM ET)
Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026
Business Wire (Thu, 23-Apr 4:01 PM ET)
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
Doximity Class A trades on the NYSE stock market under the symbol DOCS.
As of June 9, 2026, DOCS stock price climbed to $20.45 with 3,829,656 million shares trading.
DOCS has a beta of 2.05, meaning it tends to be more sensitive to market movements. DOCS has a correlation of 0.16 to the broad based SPY ETF.
DOCS has a market cap of $3.74 billion. This is considered a Mid Cap stock.
Last quarter Doximity Class A reported $145 million in Revenue and $.26 earnings per share. This beat revenue expectation by $2 million and met earnings estimates .
In the last 3 years, DOCS traded as high as $85.21 and as low as $17.15.
The top ETF exchange traded funds that DOCS belongs to (by Net Assets): VTI, IJH, VB, VBK, VXF.
DOCS has underperformed the market in the last year with a return of -64.8%, while the SPY ETF gained +24.1%. In the last 3 month period, DOCS fell short of the market, returning -19.8%, while SPY returned +8.9%. However, in the most recent 2 weeks DOCS has outperformed the stock market by returning +4.8%, while SPY returned -1.8%.
DOCS support price is $19.66 and resistance is $20.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOCS shares will trade within this expected range on the day.